Advocacy intelligence hub — real-time data for patient organizations
Anjali Sharathkumar — PHASE2
Medical College of Wisconsin
Institute of Hematology & Blood Diseases Hospital, China
The First Affiliated Hospital of Soochow University — PHASE2
Qilu Pharmaceutical Co., Ltd. — PHASE3
Institute of Hematology & Blood Diseases Hospital, China — PHASE1, PHASE2
Institute of Hematology & Blood Diseases Hospital, China — PHASE1, PHASE2
Assiut University
Peking University People's Hospital — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Travel grants
Travel Grants1
Taiho Oncology Patient Support Services
Taiho Oncology
He Huang, MD
Zhejiang University
📍 Hanzhou, Zhejiang
Huang Jinbo, MD.
Chinese Academy of Medical Sciences
📍 Tianjin, Tianjin Municipality
Xiaohui Zhang, MD, MD
Peking University People's Hospital
📍 Beijing, FL
Jun Shi, PhD
Regenerative Medicine Center and Red Blood Cell Disorders Center
📍 Tianjin, Tianjin Municipality
Jingyu Zhao, MPH
Regenerative Medicine Center
📍 Tianjin, Tianjin Municipality
Hirohito Yamazaki
Kanazawa University, College of Medical Pharmaceutical and Health Sciences, School of Medicine, Department of Hematology
📍 Kanazawa, Ishikawa-ken